evaluation of amnesic produced by oral midazolam and intranasal dexmedetomidine in pediatric patients: a randomized clinical study

amnesic effect of oral midazolam and intranasal dexmedetomidine in children: a randomized clinical study - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105433

Enrollment

Registered

2026-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K04- Diseases of pulp and periapical tissues

Interventions

Intervention1: comparative evaluation of the amnesic effect of oral Midazolam and intranasal dexmedetomidine with nitrous oxide oxygen in children: amnesic effect comparing the two sedatives Intervent

Eligibility

Inclusion criteria

Inclusion criteria: ASA category - 1 childs weight within normal range frankls positive or negative behavior children with at least 2 carious lesions

Exclusion criteria

Exclusion criteria: children with identifiable risk factors for airway obstruction, such as enlarged tonsils or adenoids, nasal polyps, septal deviation and a mallampati score of 3 or 4

Design outcomes

Primary

Measure	Time frame
amnesic effect of midazolam compared to dexmedetomidine.Timepoint: assessed every 15 minutes till the procedure ends.	—

Secondary

Measure	Time frame
ramsay sedation scoringTimepoint: 15 minutes after administration of the drug	—

Countries

India

Contacts

Public Contactpooja nellore

Manipal College of Dental Sciences Mangalore

poojanellore94@gmail.com9581224480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026